Access! 2021 | Association for Accessible Medicines
In the News - View AAM CEO Dan Leonard's blog on the essential role generic drugs play during COVID-19

Access! 2021

May 26-27, 2021

Join us for Access!™ 2021 virtual conference May 26-27, 2021.

AAM's Annual Meeting Access! 2021 brings together policymakers, influential speakers and industry leaders to chart the future of generics and biosimilars. Discussions center around the business, breakthroughs and politics that shape our industry. It’s the opportunity to hear firsthand from world-renowned speakers and learn about where our industry is heading and what our future holds.

Register Now

 

Why You Should Attend

We’ve made it easier now than ever before to attend the conference. No matter where you are physically on May 26-27 you will be able to attend. Access! 2021 is a fully interactive conference with the ability to chat with other conference attendees, speakers and exhibitors. You will also be able to download conference materials to review later.

  • Access to the latest information about generics and biosimilars

  • Insights into the future of our industry

  • Interaction with leaders in the industry

  • Opportunities to network with industry peers

EXPO

Showcase your company at Access! 2021. Don’t miss out on this highly interactive and professional business environment in which industry vendors can meet generics and biosimilars industry executives. We offer our exhibitors abundant networking time with industry decision-makers.

Sponsorship Opportunities

Raise your company profile by participating in this prestigious event. For more information regarding sponsorship levels and benefits, contact Jennifer Soup at jennifer.soup@accessiblemeds.org.

Fees

AAM / Biosimilars Council Member Fee - $599.00
Nonmember Fee - $899.00
Government Fee - $399.00

Subscribe for Information

Be the first to know about updates regarding Access! 2021. Please complete the form below and we’ll add you to our mailing list.

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.